• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶节段性肾小球硬化的发病机制

Pathogenesis of Focal Segmental Glomerulosclerosis.

作者信息

Lim Beom Jin, Yang Jae Won, Do Woo Sung, Fogo Agnes B

机构信息

Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Korea.

出版信息

J Pathol Transl Med. 2016 Nov;50(6):405-410. doi: 10.4132/jptm.2016.09.21. Epub 2016 Oct 16.

DOI:10.4132/jptm.2016.09.21
PMID:27744657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5122732/
Abstract

Focal segmental glomerulosclerosis (FSGS) is characterized by focal and segmental obliteration of glomerular capillary tufts with increased matrix. FSGS is classified as collapsing, tip, cellular, perihilar and not otherwise specified variants according to the location and character of the sclerotic lesion. Primary or idiopathic FSGS is considered to be related to podocyte injury, and the pathogenesis of podocyte injury has been actively investigated. Several circulating factors affecting podocyte permeability barrier have been proposed, but not proven to cause FSGS. FSGS may also be caused by genetic alterations. These genes are mainly those regulating slit diaphragm structure, actin cytoskeleton of podocytes, and foot process structure. The mode of inheritance and age of onset are different according to the gene involved. Recently, the role of parietal epithelial cells (PECs) has been highlighted. Podocytes and PECs have common mesenchymal progenitors, therefore, PECs could be a source of podocyte repopulation after podocyte injury. Activated PECs migrate along adhesion to the glomerular tuft and may also contribute to the progression of sclerosis. Markers of activated PECs, including CD44, could be used to distinguish FSGS from minimal change disease. The pathogenesis of FSGS is very complex; however, understanding basic mechanisms of podocyte injury is important not only for basic research, but also for daily diagnostic pathology practice.

摘要

局灶节段性肾小球硬化(FSGS)的特征是肾小球毛细血管袢局灶性和节段性闭塞伴基质增加。根据硬化病变的部位和特征,FSGS可分为塌陷型、顶端型、细胞型、肾小球旁型及未分类型。原发性或特发性FSGS被认为与足细胞损伤有关,且对足细胞损伤的发病机制已进行了积极研究。已提出几种影响足细胞通透屏障的循环因子,但尚未证实其可导致FSGS。FSGS也可能由基因改变引起。这些基因主要是调节裂孔隔膜结构、足细胞肌动蛋白细胞骨架和足突结构的基因。根据所涉及的基因不同,遗传方式和发病年龄也有所不同。最近,壁层上皮细胞(PEC)的作用受到了关注。足细胞和PEC有共同的间充质祖细胞,因此,PEC可能是足细胞损伤后足细胞再填充的来源。活化的PEC沿黏附迁移至肾小球袢,也可能促进硬化的进展。活化PEC的标志物,包括CD44,可用于鉴别FSGS和微小病变肾病。FSGS的发病机制非常复杂;然而,了解足细胞损伤的基本机制不仅对基础研究很重要,对日常诊断病理实践也很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01b/5122732/2c206ed85c68/jptm-2016-09-21f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01b/5122732/2c206ed85c68/jptm-2016-09-21f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01b/5122732/2c206ed85c68/jptm-2016-09-21f1.jpg

相似文献

1
Pathogenesis of Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化的发病机制
J Pathol Transl Med. 2016 Nov;50(6):405-410. doi: 10.4132/jptm.2016.09.21. Epub 2016 Oct 16.
2
Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.小鼠模型中的局灶节段性肾小球硬化:肾小球CD44和WT1表达的免疫组化相关性的组织学和超微结构特征
Ultrastruct Pathol. 2018 Sep-Oct;42(5):430-439. doi: 10.1080/01913123.2018.1501125. Epub 2018 Oct 4.
3
HIV-associated nephropathy: experimental models.人类免疫缺陷病毒相关性肾病:实验模型
Contrib Nephrol. 2011;169:270-285. doi: 10.1159/000320212. Epub 2011 Jan 20.
4
Focal segmental glomerulosclerosis; why does it occur segmentally?局灶节段性肾小球硬化;为何它呈节段性发生?
Pflugers Arch. 2017 Aug;469(7-8):983-988. doi: 10.1007/s00424-017-2023-x. Epub 2017 Jun 29.
5
Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.局灶节段性肾小球硬化中的足细胞和内皮细胞损伤:超微结构分析
Virchows Arch. 2015 Oct;467(4):449-58. doi: 10.1007/s00428-015-1821-9. Epub 2015 Aug 13.
6
Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis.肾小球壁层上皮细胞在实验性局灶节段性肾小球硬化中对成年足细胞再生有贡献。
Kidney Int. 2015 Nov;88(5):999-1012. doi: 10.1038/ki.2015.152. Epub 2015 May 20.
7
Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis.足细胞损伤过程中 MIF 和 SDF1 的双相表达促进局灶节段性肾小球硬化中 CD44 介导的肾小球壁细胞迁移。
Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F741-F753. doi: 10.1152/ajprenal.00414.2019. Epub 2020 Feb 18.
8
E pluribus unum: The riddle of focal segmental glomerulosclerosis.合众为一:局灶节段性肾小球硬化之谜。
Semin Nephrol. 2003 Mar;23(2):135-40. doi: 10.1053/snep.2003.50013.
9
Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.CD44 阳性肾小球壁层上皮细胞的患病率反映了阿霉素肾病中足细胞的损伤。
Nephron Exp Nephrol. 2013;124(3-4):11-8. doi: 10.1159/000357356. Epub 2014 Jan 8.
10
Diverse Alterations of Glomerular Capillary Networks in Focal Segmental Glomerular Sclerosis.局灶节段性肾小球硬化中肾小球毛细血管网络的多种改变
Kidney Int Rep. 2022 Mar 14;7(6):1229-1240. doi: 10.1016/j.ekir.2022.03.007. eCollection 2022 Jun.

引用本文的文献

1
Clinical implications of apolipoprotein L1 testing in patients with focal segmental glomerulosclerosis: a review of diagnostic and prognostic implications.局灶节段性肾小球硬化患者载脂蛋白L1检测的临床意义:诊断和预后意义综述
Ann Med Surg (Lond). 2025 Mar 3;87(3):1543-1551. doi: 10.1097/MS9.0000000000003051. eCollection 2025 Mar.
2
Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study.嘌呤能受体激活对血管紧张素 II 诱导的高血压中肾小球微血管免受机械应力增加的保护作用:一项建模研究。
Int J Mol Sci. 2025 Feb 24;26(5):1928. doi: 10.3390/ijms26051928.
3

本文引用的文献

1
Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.可溶性尿激酶受体水平与IgA肾病中的局灶节段性肾小球硬化病变相关:一项来自中国的队列研究
PLoS One. 2015 Sep 18;10(9):e0138718. doi: 10.1371/journal.pone.0138718. eCollection 2015.
2
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.半乳糖和阿达木单抗治疗抵抗性局灶节段性肾小球硬化症患者的疗效:Font临床试验组报告
BMC Nephrol. 2015 Jul 22;16:111. doi: 10.1186/s12882-015-0094-5.
3
Focal segmental glomerulosclerosis: molecular genetics and targeted therapies.
Podocyte A20/TNFAIP3 Controls Glomerulonephritis Severity via the Regulation of Inflammatory Responses and Effects on the Cytoskeleton.
足细胞A20/TNFAIP3通过调节炎症反应和对细胞骨架的作用来控制肾小球肾炎的严重程度。
Cells. 2025 Mar 5;14(5):381. doi: 10.3390/cells14050381.
4
Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China.钙调磷酸酶抑制剂或环磷酰胺治疗合并 FSGS 病变的膜性肾病:来自中国的回顾性研究。
Ren Fail. 2023;45(2):2253930. doi: 10.1080/0886022X.2023.2253930. Epub 2023 Sep 19.
5
Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?利妥昔单抗治疗原发性局灶节段性肾小球硬化:是时候将其应用于常规临床实践了吗?
Clin Kidney J. 2023 May 24;16(8):1199-1205. doi: 10.1093/ckj/sfad122. eCollection 2023 Aug.
6
High Rate of Mutations of Adhesion Molecules and Extracellular Matrix Glycoproteins in Patients with Adult-Onset Focal and Segmental Glomerulosclerosis.成人起病的局灶节段性肾小球硬化患者中黏附分子和细胞外基质糖蛋白的高突变率
Biomedicines. 2023 Jun 20;11(6):1764. doi: 10.3390/biomedicines11061764.
7
Identification of key biomarkers of the glomerulus in focal segmental glomerulosclerosis and their relationship with immune cell infiltration based on WGCNA and the LASSO algorithm.基于 WGCNA 和 LASSO 算法鉴定局灶节段性肾小球硬化肾小球中的关键生物标志物及其与免疫细胞浸润的关系。
Ren Fail. 2023 Dec;45(1):2202264. doi: 10.1080/0886022X.2023.2202264.
8
The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis.HLA 抗原在复发性原发性局灶节段性肾小球硬化中的作用。
Front Immunol. 2023 Feb 23;14:1124249. doi: 10.3389/fimmu.2023.1124249. eCollection 2023.
9
Small Nucleolar RNAs in Pseudoexfoliation Glaucoma.小核仁 RNA 在假性剥脱性青光眼。
Cells. 2022 Sep 2;11(17):2738. doi: 10.3390/cells11172738.
10
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease.单基因局灶节段性肾小球硬化症:一种用于识别和管理异质性疾病的概念框架。
Am J Med Genet C Semin Med Genet. 2022 Sep;190(3):377-398. doi: 10.1002/ajmg.c.31990. Epub 2022 Jul 27.
局灶节段性肾小球硬化:分子遗传学与靶向治疗
BMC Nephrol. 2015 Jul 9;16:101. doi: 10.1186/s12882-015-0090-9.
4
Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.Janus激酶2/信号转导及转录激活因子3抑制剂可减弱类心肌营养素因子1和人类局灶节段性肾小球硬化血清对肾小球滤过屏障的作用。
Transl Res. 2015 Oct;166(4):384-98. doi: 10.1016/j.trsl.2015.03.002. Epub 2015 Mar 16.
5
Tip variant of focal segmental glomerulosclerosis: is it truly a benign variant?局灶节段性肾小球硬化的尖端变异型:它真的是一种良性变异型吗?
Ren Fail. 2015 Jun;37(5):763-8. doi: 10.3109/0886022X.2015.1014755. Epub 2015 Feb 27.
6
Defects of CRB2 cause steroid-resistant nephrotic syndrome.CRB2 基因突变导致类固醇耐药性肾病综合征。
Am J Hum Genet. 2015 Jan 8;96(1):153-61. doi: 10.1016/j.ajhg.2014.11.014. Epub 2014 Dec 31.
7
Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China.血浆可溶性尿激酶型纤溶酶原激活物受体水平与狼疮性肾炎的临床及病理活动相关:一项来自中国的大型队列研究
Lupus. 2015 May;24(6):546-57. doi: 10.1177/0961203314558857. Epub 2014 Nov 18.
8
Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.肾小球簇上活化的壁层上皮细胞的检测可将早期局灶节段性肾小球硬化与微小病变疾病区分开来。
Am J Pathol. 2014 Dec;184(12):3239-48. doi: 10.1016/j.ajpath.2014.08.007. Epub 2014 Oct 7.
9
Familial FSGS.家族性局灶节段性肾小球硬化症
Adv Chronic Kidney Dis. 2014 Sep;21(5):422-5. doi: 10.1053/j.ackd.2014.06.001.
10
The pathogenesis of focal segmental glomerulosclerosis.局灶节段性肾小球硬化的发病机制。
Adv Chronic Kidney Dis. 2014 Sep;21(5):408-16. doi: 10.1053/j.ackd.2014.05.009.